Ligand Pharmaceuticals, Inc. (LGND)
280.18
-6.11
(-2.13%)
USD |
NASDAQ |
Aug 24, 16:00
280.04
-0.14
(-0.05%)
After-Hours: 20:00
Ligand Pharmaceuticals Market Cap : 5.581B for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 24, 2026 | 5.581B |
| August 21, 2026 | 5.703B |
| August 20, 2026 | 5.725B |
| August 19, 2026 | 5.791B |
| August 18, 2026 | 5.729B |
| August 17, 2026 | 5.812B |
| August 14, 2026 | 5.868B |
| August 13, 2026 | 5.753B |
| August 12, 2026 | 5.842B |
| August 11, 2026 | 5.752B |
| August 10, 2026 | 5.890B |
| August 07, 2026 | 5.840B |
| August 06, 2026 | 5.979B |
| August 05, 2026 | 6.027B |
| August 04, 2026 | 6.025B |
| August 03, 2026 | 5.849B |
| July 31, 2026 | 5.759B |
| July 30, 2026 | 5.934B |
| July 29, 2026 | 5.769B |
| July 28, 2026 | 5.934B |
| July 27, 2026 | 5.959B |
| July 24, 2026 | 6.019B |
| July 23, 2026 | 6.052B |
| July 22, 2026 | 6.094B |
| July 21, 2026 | 6.118B |
| Date | Value |
|---|---|
| July 20, 2026 | 5.888B |
| July 17, 2026 | 6.077B |
| July 16, 2026 | 5.938B |
| July 15, 2026 | 5.934B |
| July 14, 2026 | 6.028B |
| July 13, 2026 | 6.194B |
| July 10, 2026 | 6.334B |
| July 09, 2026 | 6.462B |
| July 08, 2026 | 6.307B |
| July 07, 2026 | 6.398B |
| July 06, 2026 | 6.418B |
| July 02, 2026 | 6.400B |
| July 01, 2026 | 6.249B |
| June 30, 2026 | 6.331B |
| June 29, 2026 | 6.290B |
| June 26, 2026 | 6.081B |
| June 25, 2026 | 5.927B |
| June 24, 2026 | 5.706B |
| June 23, 2026 | 5.597B |
| June 22, 2026 | 5.251B |
| June 18, 2026 | 5.506B |
| June 17, 2026 | 5.270B |
| June 16, 2026 | 5.112B |
| June 15, 2026 | 5.072B |
| June 12, 2026 | 5.118B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Johnson & Johnson | 657.54B |
| Eli Lilly & Co. | 1.174T |
| Merck & Co., Inc. | 371.93B |
| Zevra Therapeutics, Inc. | 691.33M |
| Liquidia Corp. | 6.261B |
Market Cap Related Metrics
| PE Ratio | 29.95 |
| PS Ratio | 20.13 |
| Price to Book Value | 5.769 |
| Price to Free Cash Flow | 48.80 |
| Price | 280.18 |
| Earnings Yield | 3.34% |
| Operating PE Ratio | 58.42 |
| Normalized PE Ratio | 39.81 |